| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery.
|
N Engl J Med
|
2010
|
22.04
|
|
2
|
Transcatheter versus surgical aortic-valve replacement in high-risk patients.
|
N Engl J Med
|
2011
|
15.70
|
|
3
|
Two-year outcomes after transcatheter or surgical aortic-valve replacement.
|
N Engl J Med
|
2012
|
6.27
|
|
4
|
Transcatheter aortic-valve replacement for inoperable severe aortic stenosis.
|
N Engl J Med
|
2012
|
4.47
|
|
5
|
5-year outcomes of transcatheter aortic valve replacement compared with standard treatment for patients with inoperable aortic stenosis (PARTNER 1): a randomised controlled trial.
|
Lancet
|
2015
|
4.01
|
|
6
|
Health-related quality of life after transcatheter or surgical aortic valve replacement in high-risk patients with severe aortic stenosis: results from the PARTNER (Placement of AoRTic TraNscathetER Valve) Trial (Cohort A).
|
J Am Coll Cardiol
|
2012
|
3.29
|
|
7
|
Long-term outcomes of inoperable patients with aortic stenosis randomly assigned to transcatheter aortic valve replacement or standard therapy.
|
Circulation
|
2014
|
3.04
|
|
8
|
Cost-effectiveness of transcatheter aortic valve replacement compared with standard care among inoperable patients with severe aortic stenosis: results from the placement of aortic transcatheter valves (PARTNER) trial (Cohort B).
|
Circulation
|
2012
|
2.71
|
|
9
|
Cost-effectiveness of transcatheter aortic valve replacement compared with surgical aortic valve replacement in high-risk patients with severe aortic stenosis: results of the PARTNER (Placement of Aortic Transcatheter Valves) trial (Cohort A).
|
J Am Coll Cardiol
|
2012
|
2.56
|
|
10
|
5-year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial.
|
Lancet
|
2015
|
2.43
|
|
11
|
The impact of frailty status on survival after transcatheter aortic valve replacement in older adults with severe aortic stenosis: a single-center experience.
|
JACC Cardiovasc Interv
|
2012
|
2.08
|
|
12
|
Atrial Fibrillation Is Associated With Increased Mortality in Patients Undergoing Transcatheter Aortic Valve Replacement: Insights From the Placement of Aortic Transcatheter Valve (PARTNER) Trial.
|
Circ Cardiovasc Interv
|
2016
|
2.05
|
|
13
|
Appropriate patient selection or health care rationing? Lessons from surgical aortic valve replacement in the Placement of Aortic Transcatheter Valves I trial.
|
J Thorac Cardiovasc Surg
|
2015
|
2.02
|
|
14
|
Health-related quality of life after transcatheter aortic valve replacement in inoperable patients with severe aortic stenosis.
|
Circulation
|
2011
|
1.79
|
|
15
|
Comparison of transcatheter and surgical aortic valve replacement in severe aortic stenosis: a longitudinal study of echocardiography parameters in cohort A of the PARTNER trial (placement of aortic transcatheter valves).
|
J Am Coll Cardiol
|
2013
|
1.79
|
|
16
|
Stratification of outcomes after transcatheter aortic valve replacement according to surgical inoperability for technical versus clinical reasons.
|
J Am Coll Cardiol
|
2013
|
1.67
|
|
17
|
Comprehensive analysis of mortality among patients undergoing TAVR: results of the PARTNER trial.
|
J Am Coll Cardiol
|
2014
|
1.63
|
|
18
|
Predictors and clinical outcomes of permanent pacemaker implantation after transcatheter aortic valve replacement: the PARTNER (Placement of AoRtic TraNscathetER Valves) trial and registry.
|
JACC Cardiovasc Interv
|
2015
|
1.62
|
|
19
|
Incidence, predictors, and prognostic impact of late bleeding complications after transcatheter aortic valve replacement.
|
J Am Coll Cardiol
|
2014
|
1.57
|
|
20
|
Incidence and sequelae of prosthesis-patient mismatch in transcatheter versus surgical valve replacement in high-risk patients with severe aortic stenosis: a PARTNER trial cohort--a analysis.
|
J Am Coll Cardiol
|
2014
|
1.52
|
|
21
|
Costs of periprocedural complications in patients treated with transcatheter aortic valve replacement: results from the Placement of Aortic Transcatheter Valve trial.
|
Circ Cardiovasc Interv
|
2014
|
1.49
|
|
22
|
Outcomes of transcatheter and surgical aortic valve replacement in high-risk patients with aortic stenosis and left ventricular dysfunction: results from the Placement of Aortic Transcatheter Valves (PARTNER) trial (cohort A).
|
Circ Cardiovasc Interv
|
2013
|
1.48
|
|
23
|
Sex-Specific Differences at Presentation and Outcomes Among Patients Undergoing Transcatheter Aortic Valve Replacement: A Cohort Study.
|
Ann Intern Med
|
2016
|
1.46
|
|
24
|
Trends in Complications and Outcomes of Patients Undergoing Transfemoral Transcatheter Aortic Valve Replacement: Experience From the PARTNER Continued Access Registry.
|
JACC Cardiovasc Interv
|
2016
|
1.43
|
|
25
|
The relative performance characteristics of the logistic European System for Cardiac Operative Risk Evaluation score and the Society of Thoracic Surgeons score in the Placement of Aortic Transcatheter Valves trial.
|
J Thorac Cardiovasc Surg
|
2014
|
1.42
|
|
26
|
Transcatheter aortic valve replacement and standard therapy in inoperable patients with aortic stenosis and low EF.
|
Heart
|
2015
|
1.42
|
|
27
|
A Review of the Key Clinical Trials of 2014.
|
Cardiol Ther
|
2015
|
1.38
|
|
28
|
Outcomes after transfemoral transcatheter aortic valve replacement: a comparison of the randomized PARTNER (Placement of AoRTic TraNscathetER Valves) trial with the NRCA (Nonrandomized Continued Access) registry.
|
JACC Cardiovasc Interv
|
2014
|
1.37
|
|
29
|
Predictors of poor outcomes after transcatheter aortic valve replacement: results from the PARTNER (Placement of Aortic Transcatheter Valve) trial.
|
Circulation
|
2014
|
1.34
|
|
30
|
Transcatheter versus surgical aortic valve replacement in patients with diabetes and severe aortic stenosis at high risk for surgery: an analysis of the PARTNER Trial (Placement of Aortic Transcatheter Valve).
|
J Am Coll Cardiol
|
2013
|
1.26
|
|
31
|
Bleeding complications after surgical aortic valve replacement compared with transcatheter aortic valve replacement: insights from the PARTNER I Trial (Placement of Aortic Transcatheter Valve).
|
J Am Coll Cardiol
|
2013
|
1.21
|
|
32
|
Predictors of mortality and outcomes of therapy in low-flow severe aortic stenosis: a Placement of Aortic Transcatheter Valves (PARTNER) trial analysis.
|
Circulation
|
2013
|
1.15
|
|
33
|
Transcatheter (TAVR) versus surgical (AVR) aortic valve replacement: occurrence, hazard, risk factors, and consequences of neurologic events in the PARTNER trial.
|
J Thorac Cardiovasc Surg
|
2012
|
1.12
|
|
34
|
Relation of frailty to outcomes after transcatheter aortic valve replacement (from the PARTNER trial).
|
Am J Cardiol
|
2015
|
1.08
|
|
35
|
Insights Into Timing, Risk Factors, and Outcomes of Stroke and Transient Ischemic Attack After Transcatheter Aortic Valve Replacement in the PARTNER Trial (Placement of Aortic Transcatheter Valves).
|
Circ Cardiovasc Interv
|
2016
|
1.07
|
|
36
|
Incidence and effect of acute kidney injury after transcatheter aortic valve replacement using the new valve academic research consortium criteria.
|
Am J Cardiol
|
2012
|
1.07
|
|
37
|
Impact of preoperative moderate/severe mitral regurgitation on 2-year outcome after transcatheter and surgical aortic valve replacement: insight from the Placement of Aortic Transcatheter Valve (PARTNER) Trial Cohort A.
|
Circulation
|
2013
|
1.00
|
|
38
|
Relation between six-minute walk test performance and outcomes after transcatheter aortic valve implantation (from the PARTNER trial).
|
Am J Cardiol
|
2013
|
0.98
|
|
39
|
Sex-related differences in outcomes after transcatheter or surgical aortic valve replacement in patients with severe aortic stenosis: Insights from the PARTNER Trial (Placement of Aortic Transcatheter Valve).
|
J Am Coll Cardiol
|
2014
|
0.93
|
|
40
|
Chronic pacing and adverse outcomes after transcatheter aortic valve implantation.
|
Heart
|
2015
|
0.88
|
|
41
|
Beyond adding years to life: health-related quality-of-life and functional outcomes in patients with severe aortic valve stenosis at high surgical risk undergoing transcatheter aortic valve replacement.
|
Curr Cardiol Rev
|
2013
|
0.87
|
|
42
|
Outcomes of patients with chronic lung disease and severe aortic stenosis treated with transcatheter versus surgical aortic valve replacement or standard therapy: insights from the PARTNER trial (placement of AoRTic TraNscathetER Valve).
|
J Am Coll Cardiol
|
2013
|
0.87
|
|
43
|
Propensity-matched comparisons of clinical outcomes after transapical or transfemoral transcatheter aortic valve replacement: a placement of aortic transcatheter valves (PARTNER)-I trial substudy.
|
Circulation
|
2015
|
0.82
|
|
44
|
Outcomes in Nonagenarians Undergoing Transcatheter Aortic Valve Replacement in the PARTNER-I Trial.
|
Ann Thorac Surg
|
2015
|
0.82
|
|
45
|
Learning curves for transapical transcatheter aortic valve replacement in the PARTNER-I trial: Technical performance, success, and safety.
|
J Thorac Cardiovasc Surg
|
2016
|
0.81
|
|
46
|
Impact of aortic annulus size on valve hemodynamics and clinical outcomes after transcatheter and surgical aortic valve replacement: insights from the PARTNER Trial.
|
Circ Cardiovasc Interv
|
2014
|
0.80
|
|
47
|
Outcomes of inoperable symptomatic aortic stenosis patients not undergoing aortic valve replacement: insight into the impact of balloon aortic valvuloplasty from the PARTNER trial (Placement of AoRtic TraNscathetER Valve trial).
|
JACC Cardiovasc Interv
|
2015
|
0.79
|
|
48
|
Risk stratification in patients with pulmonary hypertension undergoing transcatheter aortic valve replacement.
|
Heart
|
2015
|
0.78
|
|
49
|
Analysis of early out-of hospital mortality after transcatheter aortic valve implantation among patients with aortic stenosis successfully discharged from the hospital and alive at 30 days (from the placement of aortic transcatheter valves trial).
|
Am J Cardiol
|
2014
|
0.78
|
|
50
|
Transcatheter heart-valve replacement: update.
|
CMAJ
|
2010
|
0.77
|
|
51
|
Hemodynamic outcomes of transcatheter aortic valve replacement and medical management in severe, inoperable aortic stenosis: a longitudinal echocardiographic study of cohort B of the PARTNER trial.
|
J Am Soc Echocardiogr
|
2014
|
0.76
|
|
52
|
Determinants and outcomes of acute transcatheter valve-in-valve therapy or embolization: a study of multiple valve implants in the U.S. PARTNER trial (Placement of AoRTic TraNscathetER Valve Trial Edwards SAPIEN Transcatheter Heart Valve).
|
J Am Coll Cardiol
|
2013
|
0.76
|
|
53
|
Long-Term Valve Performance of TAVR and SAVR: A Report From the PARTNER I Trial.
|
JACC Cardiovasc Imaging
|
2016
|
0.75
|
|
54
|
Does transcatheter aortic valve implantation mean the end of surgical aortic valve replacement?
|
Tex Heart Inst J
|
2010
|
0.75
|
|
55
|
Evaluation of Flow After Transcatheter Aortic Valve Replacement in Patients With Low-Flow Aortic Stenosis: A Secondary Analysis of the PARTNER Randomized Clinical Trial.
|
JAMA Cardiol
|
2016
|
0.75
|
|
56
|
Temporal Trends in Quality of Life Outcomes After Transapical Transcatheter Aortic Valve Replacement: A Placement of AoRTic TraNscathetER Valve (PARTNER) Trial Substudy.
|
Circ Cardiovasc Qual Outcomes
|
2015
|
0.75
|
|
57
|
Safety of percutaneous aortic valve insertion. A systematic review.
|
BMC Cardiovasc Disord
|
2009
|
0.75
|